3 TSX Tech Stocks to Buy After They Surrendered Some of Their Gains

These TSX tech companies are looking attractive after the recent decline in their stock prices.

| More on:
tech and analysis

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

TSX-listed tech stocks outperformed the broader markets in 2020, with most of them delivering robust returns so far this year. However, in the recent past, profit booking and focus shift towards companies that could recover fast in a post-pandemic world have led to a pullback in tech stocks. 

Shares of almost all tech companies surrendered some of their gains, and a few are looking attractive at the current levels. We’ll focus on three tech stocks that have retraced from their peak and have the potential to deliver outsized gains over time. 

Real Matters 

Shares of Real Matters (TSX:REAL) are up over 105% year to date, as the company’s tech-based platform witnessed increased volumes owing to the surge in mortgage refinancing activities amid lower interest rates. 

Thanks to the stellar demand, Real Matters reported consolidated adjusted EBITDA of US$20.9 in Q3, which more than doubled from the prior-year period. Meanwhile, adjusted EBITDA margin expanded significantly, reflecting higher closings and mix shift toward higher-margin U.S. title operations. 

However, Real Matters stock has corrected by over 23% from its 52-week high of $33.01. The decline offers a good buying opportunity for investors with a medium- to the longer-term investment horizon. 

Real Matters could continue to benefit from the lower interest rate environment. The demand for mortgage refinancing in the U.S. is likely to sustain and should drive Real Matters’s revenues and adjusted EBITDA. Besides favourable industry trends, Real Matters stock could continue to benefit from its large blue-chip client base, high client retention rate, and large addressable market.

Dye & Durham

Shares of Dye & Durham (TSX:DND) soared significantly from its IPO price of $7. However, the shares of legal technology company dropped about 25% from its 52-week high of $28.68, as the temporary closure of courthouses due to the pandemic took a toll on its revenues and EBITDA.

Thanks to the reopening of the economy, Dye & Durham bounced back strongly and reported stark sequential improvement in its sales and adjusted EBITDA during the recently concluded first quarter of fiscal 2021. Dye & Durham expects momentum across its product lines to sustain in the coming quarters and forecasts revenue growth of about 64% in the second quarter of fiscal 2021. 

Meanwhile, the company’s strong fundamentals position it well to deliver double-digit sales and EBITDA growth over the next several years. Dye & Durham’s ability to acquire and integrate fast-growing companies, broadening customer base, and extension of its platform augur well for growth and should support the upside in its stock. 

Kinaxis 

Kinaxis (TSX:KXS) has been a consistent performer and has generated multi-fold returns for its investors over the past several years. While its stock is up about 67% year to date, it has declined by about 26% from its 52-week high of $224.98.

The retracement presents an excellent opportunity to go long on Kinaxis stock. Kinaxis continues to benefit from sustain demand for its supply-chain software and solutions as reflected through its growing customer base and strong order backlog. 

While Kinaxis’s base business remains strong, its acquisition of Rubikloud is likely to further accelerate its growth rate by expanding its reach into the enterprise retail industry. Meanwhile, the growing share of the recurring revenue base, higher client retention rate, and expansion through accretive acquisitions position it well to deliver outsized growth over the next decade. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Sneha Nahata has no position in any of the stocks mentioned. The Motley Fool recommends KINAXIS INC and Real Matters Inc.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »